{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:47Z","timestamp":1786982207400,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Horizontal Project of Xi\u2019an Jiaotong University","award":["202411193"],"award-info":[{"award-number":["202411193"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03120-6","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:20:38Z","timestamp":1763965238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["UPP1\/ARNT positive feedback loop drives gastric cancer progression through metabolism reprogramming"],"prefix":"10.1007","volume":"43","author":[{"given":"Xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanning","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangpeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"3","key":"3120_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"3120_CR2","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1200\/JCO.23.01601","volume":"42","author":"YY Janjigian","year":"2024","unstructured":"Janjigian YY, Ajani JA, Moehler M, Shen L, Garrido M, Gallardo C, et al. First-line nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 3-year follow-up of the phase III checkmate 649 trial. J Clin Oncol. 2024;42(17):2012\u201320. https:\/\/doi.org\/10.1200\/JCO.23.01601.","journal-title":"J Clin Oncol"},{"issue":"23","key":"3120_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70439","volume":"13","author":"J Ye","year":"2024","unstructured":"Ye J, Wu S, Quan Q, Ye F, Zhang J, Song C, et al. Fibroblast growth factor receptor 4 promotes triple-negative breast cancer progression via regulating fatty acid metabolism through the AKT\/RYR2 signaling. Cancer Med. 2024;13(23):e70439. https:\/\/doi.org\/10.1002\/cam4.70439.","journal-title":"Cancer Med"},{"issue":"8","key":"3120_CR4","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.7150\/thno.71833","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Hu X, Lin R, Zhou G, Zhao L, Zhao D, et al. Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer. Theranostics. 2022;12(8):3818\u201333. https:\/\/doi.org\/10.7150\/thno.71833.","journal-title":"Theranostics"},{"issue":"12","key":"3120_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","volume":"14","author":"WH Fridman","year":"2017","unstructured":"Fridman WH, Zitvogel L, Saut\u00e8s-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14(12):717\u201334. https:\/\/doi.org\/10.1038\/nrclinonc.2017.101.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"3120_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350. https:\/\/doi.org\/10.1038\/s41591-018-0014-x.","journal-title":"Nat Med"},{"issue":"5","key":"3120_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s42255-023-00774-2","volume":"5","author":"OS Skinner","year":"2023","unstructured":"Skinner OS, Blanco-Fern\u00e1ndez J, Goodman RP, Kawakami A, Shen H, Kem\u00e9ny LV, et al. Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions. Nat Metab. 2023;5(5):765\u201376. https:\/\/doi.org\/10.1038\/s42255-023-00774-2.","journal-title":"Nat Metab"},{"issue":"7963","key":"3120_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41586-023-06073-w","volume":"618","author":"ZC Nwosu","year":"2023","unstructured":"Nwosu ZC, Ward MH, Sajjakulnukit P, Poudel P, Ragulan C, Kasperek S, Radyk M, Sutton D, Menjivar RE, Andren A, Apiz-Saab JJ, Tolstyka Z, Brown K, Lee HJ, Dzierozynski LN, He X, Ps H, Ugras J, Nyamundanda G, Zhang L, Halbrook CJ, Carpenter ES, Shi J, Shriver LP, Patti GJ, Muir A, Magliano M, Sadanandam A, Lyssiotis CA. Uridine-derived ribose fuels glucose-restricted pancreatic cancer. Nature. 2023;618(7963):151\u20138. https:\/\/doi.org\/10.1038\/s41586-023-06073-w.","journal-title":"Nature"},{"issue":"1","key":"3120_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45340-w","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Jiang M, Aye L, Luo L, Zhang Y, Xu F, et al. UPP1 promotes lung adeno-carcinoma progression through the induction of an immunosuppressive microenvironment. Nat Commun. 2024;15(1):1200. https:\/\/doi.org\/10.1038\/s41467-024-45340-w.","journal-title":"Nat Commun"},{"issue":"3","key":"3120_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1515\/mr-2024-0091","volume":"5","author":"Q Cai","year":"2024","unstructured":"Cai Q, Deng W, Zou Y, Chen ZS, Tang H. Histone lactylation as a driver of metabolic reprogramming and immune evasion. Med Rev. 2024;5(3):256\u20139. https:\/\/doi.org\/10.1515\/mr-2024-0091.","journal-title":"Med Rev"},{"issue":"3","key":"3120_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nrc2344","volume":"8","author":"RG Bristow","year":"2008","unstructured":"Bristow RG, Hill RP. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer. 2008;8(3):180\u201392. https:\/\/doi.org\/10.1038\/nrc2344.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"3120_CR12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s11427-017-9178-y","volume":"60","author":"Y Huang","year":"2017","unstructured":"Huang Y, Lin D, Taniguchi CM. Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe? Sci China Life Sci. 2017;60(10):1114\u201324. https:\/\/doi.org\/10.1007\/s11427-017-9178-y.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"3120_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2119\/molmed.2014.00032","volume":"20","author":"M Mandl","year":"2014","unstructured":"Mandl M, Depping R. Hypoxia-inducible aryl hydrocarbon receptor nuclear translocator (ARNT) (HIF-1\u03b2): is it a rare exception? Mol Med. 2014;20(1):215\u201320. https:\/\/doi.org\/10.2119\/molmed.2014.00032.","journal-title":"Mol Med"},{"issue":"6","key":"3120_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099242","volume":"9","author":"JM Shieh","year":"2014","unstructured":"Shieh JM, Shen CJ, Chang WC, Cheng HC, Chan YY, Huang WC, et al. An increase in reactive oxygen species by deregulation of ARNT enhances chemotherapeutic drug-induced cancer cell death. PLoS One. 2014;9(6):e99242. https:\/\/doi.org\/10.1371\/journal.pone.0099242.","journal-title":"PLoS One"},{"issue":"D1","key":"3120_CR15","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases, and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361. https:\/\/doi.org\/10.1093\/nar\/gkw1092.","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"3120_CR16","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1093\/bioinformatics\/btm369","volume":"23","author":"A Subramanian","year":"2007","unstructured":"Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics. 2007;23(23):3251\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btm369.","journal-title":"Bioinformatics"},{"issue":"3","key":"3120_CR17","first-page":"727","volume":"10","author":"Y Han","year":"2020","unstructured":"Han Y, Liu D, Li L. PD-1\/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020;10(3):727\u201342.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"3120_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","volume":"9","author":"PD-L1","year":"2016","unstructured":"PD-L1. Is upregulated by EBV-driven LMP1 through NF-\u03baB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma. J Hematol Oncol. 2016;9(1):109. https:\/\/doi.org\/10.1186\/s13045-016-0341-7.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"3120_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nri2423","volume":"8","author":"S Ghosh","year":"2008","unstructured":"Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol. 2008;8(11):837\u201348. https:\/\/doi.org\/10.1038\/nri2423.","journal-title":"Nat Rev Immunol"},{"key":"3120_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1102518","volume":"13","author":"Z Wu","year":"2023","unstructured":"Wu Z, Li X, Gu Z, Xia X, Yang J. Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer. Front Oncol. 2023;13:1102518. https:\/\/doi.org\/10.3389\/fonc.2023.1102518.","journal-title":"Front Oncol"},{"issue":"11","key":"3120_CR21","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1038\/s41418-021-00810-2","volume":"28","author":"C Wang","year":"2021","unstructured":"Wang C, Shi Z, Zhang Y, Li M, Zhu J, Huang Z, et al. CBF\u03b2 promotes colorectal cancer progression through transcriptionally activating OPN, FAM129A, and UPP1 in a RUNX2-dependent manner. Cell Death Differ. 2021;28(11):3176\u201392. https:\/\/doi.org\/10.1038\/s41418-021-00810-2.","journal-title":"Cell Death Differ"},{"issue":"2","key":"3120_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/s1357-2725(03)00211-5","volume":"36","author":"RJ Kewley","year":"2004","unstructured":"Kewley RJ, Whitelaw ML, Chapman-Smith A. The mammalian basic helix\u2013loop\u2013helix\/PAS family of transcriptional regulators. Int J Biochem Cell Biol. 2004;36(2):189\u2013204. https:\/\/doi.org\/10.1016\/s1357-2725(03)00211-5.","journal-title":"Int J Biochem Cell Biol"},{"key":"3120_CR23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1146\/annurev-physiol-021909-135922","volume":"72","author":"BE McIntosh","year":"2010","unstructured":"McIntosh BE, Hogenesch JB, Bradfield CA. Mammalian per-arnt-sim proteins in environmental adaptation. Int J Biochem Cell Biol. 2010;72:625\u201345. https:\/\/doi.org\/10.1146\/annurev-physiol-021909-135922.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"3120_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1464-410X.2009.08921.x","volume":"105","author":"GD Stewart","year":"2010","unstructured":"Stewart GD, et al. The relevance of a hypoxic tumour microenvironment in prostate cancer. BJU Int. 2010;105(1):8\u201313. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08921.x.","journal-title":"BJU Int"},{"issue":"1","key":"3120_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41389-020-00299-3","volume":"10","author":"CR Huang","year":"2021","unstructured":"Huang CR, Chang TW, Lee CT, et al. ARNT deficiency represses pyruvate dehydrogenase kinase 1 to trigger ROS production and melanoma metastasis. Oncogenesis. 2021;10(1):11. https:\/\/doi.org\/10.1038\/s41389-020-00299-3.","journal-title":"Oncogenesis"},{"issue":"8","key":"3120_CR26","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.32604\/or.2025.063716","volume":"33","author":"Y Wang","year":"2025","unstructured":"Wang Y, Dang H, Wang Q, Wu S, Han L, Luo XU, et al. Mitochondrial pyruvate dehydrogenase phosphatase metabolism disorder in malignant tumors. Oncol Res. 2025;33(8):1861\u201374. https:\/\/doi.org\/10.32604\/or.2025.063716.","journal-title":"Oncol Res"},{"key":"3120_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mc.20585","volume":"49","author":"S Shi","year":"2010","unstructured":"Shi S, Yoon DY, Hodge-Bell K, Huerta-Yepez S, Hankinson O. Aryl hydrocarbon nuclear translocator (hypoxia inducible factor 1\u03b2) activity is required more during early than late tumor growth. Mol Carcinog. 2010;49:157\u201365. https:\/\/doi.org\/10.1002\/mc.20585.","journal-title":"Mol Carcinog"},{"issue":"16","key":"3120_CR28","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1002\/cam4.3251","volume":"9","author":"J Wang","year":"2020","unstructured":"Wang J, et al. Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma. Cancer Med. 2020;9(16):5940\u20137. https:\/\/doi.org\/10.1002\/cam4.3251.","journal-title":"Cancer Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03120-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03120-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03120-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:51:07Z","timestamp":1769485867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03120-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3120"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03120-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Medical Ethics Committee of the Air Force Medical University\u2019s First Affiliated Hospital, and all procedures were reviewed and approved. The following provisions outline the conditions under which the waiver of informed consent applies, with explicit requirements that must be met before such an exemption can be granted. The research project with the unique identifier KY202322198-C-1 was officially sanctioned for its execution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"21"}}